AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) EV to CFO (2020 - 2023)

Updated

AbCellera Biologics' (ABCL) EV to CFO stood at 80.30 in Q3 2023, up 842.2% from 8.52 a year earlier.

Analysis

AbCellera Biologics (ABCL) EV to CFO (2020 - 2023) Analysis & Trends

On a TTM basis, AbCellera Biologics' EV to CFO came in at -292.66 as of Sep 30, 2023; for FY2022, it was 7.34, down 46.1% from FY2021.

  • Across earlier years, EV to CFO came in at 13.61 in FY2021 (-94.7%) and 256.14 in FY2020.
  • The Q3 2023 figure is the highest quarterly EV to CFO since Q4 2020.
  • On a year-over-year basis, EV to CFO rose in two of the last seven quarters, with growth averaging 72.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 AbCellera Biologics 3.89 Bn 3.89 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 80.30
Mar 31, 2023 10.27
Dec 31, 2022 7.34
Sep 30, 2022 8.52
Jun 30, 2022 5.74
Mar 31, 2022 8.45
Dec 31, 2021 13.61
Sep 30, 2021 19.49
Jun 30, 2021 20.03
Mar 31, 2021 64.02
Dec 31, 2020 256.14
API Access

AbCellera Biologics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ABCL&period=max&api_key=YOUR_API_KEY